This article first appeared on Medscape.com.
Related Articles
Comparison of Standard Dose, High Dose, and Therapeutic Anticoagulation in Hypoxemic COVID-19 Patients
July 7, 2020
Clinical question: Does standard-dose prophylactic anticoagulation (SD-PA), high-dose prophylactic anticoagulation (HD-PA), or therapeutic anticoagulation (TA) have a greater benefit in patients with...
Longer-term Outcomes in Critically Ill Patients with COVID-19 in the REMAP-CAP Trial
July 7, 2020
Clinical question: What is the longer-term (180-day) mortality effect of common therapies on critically ill patients with COVID-19? Background: Most randomized clinical trials for patients with...
Abatacept and Infliximab May Improve Mortality in Patients Hospitalized with COVID-19 Pneumonia
July 7, 2020
Dr. Rose Clinical question: What immunomodulatory drugs should we use in hospitalized patients with COVID-19 in addition to corticosteroids? Background: Inflammation is a key driver of morbidity...
Remdesivir Use Improves Mortality in COVID-19 in Non-ventilated Hospitalized Patients
July 7, 2020
Dr. Gibson Clinical question: Does remdesivir have a mortality benefit in patients with COVID-19? Background: The Solidarity trial previously reported preliminary mortality analyses for...